153 related articles for article (PubMed ID: 1570019)
1. Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter.
Wölfel R; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):129-36. PubMed ID: 1570019
[TBL] [Abstract][Full Text] [Related]
2. Effects of imipramine and some tryptamine derivatives on the efflux of 3H-5-hydroxytryptamine from rabbit platelets.
Wölfel R; Graefe KH
J Neural Transm Suppl; 1991; 34():77-83. PubMed ID: 1817167
[TBL] [Abstract][Full Text] [Related]
3. On the 5-hydroxytryptamine transport across the plasma membrane of rabbit platelets and its inhibition by imipramine.
Wölfel R; Böhm W; Halbrügge T; Bönisch H; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):1-8. PubMed ID: 3237251
[TBL] [Abstract][Full Text] [Related]
4. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
[TBL] [Abstract][Full Text] [Related]
5. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
Segonzac A; Schoemaker H; Tateishi T; Langer SZ
J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
[TBL] [Abstract][Full Text] [Related]
6. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
[TBL] [Abstract][Full Text] [Related]
7. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
[TBL] [Abstract][Full Text] [Related]
8. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
Graham D; Esnaud H; Habert E; Langer SZ
Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
[TBL] [Abstract][Full Text] [Related]
9. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.
Marcusson JO; Ross SB
Psychopharmacology (Berl); 1990; 102(2):145-55. PubMed ID: 2274599
[TBL] [Abstract][Full Text] [Related]
10. Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers.
Segonzac A; Tateishi T; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):33-7. PubMed ID: 6514017
[TBL] [Abstract][Full Text] [Related]
11. Potentiation by deprenyl of the autoreceptor-mediated inhibition of [3H]-5-hydroxytryptamine release by 5-methoxytryptamine.
Galzin AM; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):330-3. PubMed ID: 3093900
[TBL] [Abstract][Full Text] [Related]
12. Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets.
Meyerson LR; Ieni JR; Wennogle LP
J Neurochem; 1987 Feb; 48(2):560-5. PubMed ID: 3491878
[TBL] [Abstract][Full Text] [Related]
13. Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine.
O'Riordan C; Phillips OM; Williams DC
J Neurochem; 1990 Apr; 54(4):1275-80. PubMed ID: 2313287
[TBL] [Abstract][Full Text] [Related]
14. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
Cesura AM; Bertocci B; Da Prada M
Eur J Pharmacol; 1990 Sep; 186(1):95-104. PubMed ID: 2149340
[TBL] [Abstract][Full Text] [Related]
15. Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.
Segonzac A; Schoemaker H; Langer SZ
J Neurochem; 1987 Feb; 48(2):331-9. PubMed ID: 2947974
[TBL] [Abstract][Full Text] [Related]
16. Autoreceptor-mediated inhibition of 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine.
Göthert M; Schlicker E
Life Sci; 1983 Mar; 32(11):1183-91. PubMed ID: 6572776
[TBL] [Abstract][Full Text] [Related]
17. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
Andersson A; Marcusson J
Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
[TBL] [Abstract][Full Text] [Related]
18. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
Cozzi NV; Gopalakrishnan A; Anderson LL; Feih JT; Shulgin AT; Daley PF; Ruoho AE
J Neural Transm (Vienna); 2009 Dec; 116(12):1591-9. PubMed ID: 19756361
[TBL] [Abstract][Full Text] [Related]
19. Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study.
Sitte HH; Scholze P; Schloss P; Pifl C; Singer EA
J Neurochem; 2000 Mar; 74(3):1317-24. PubMed ID: 10693966
[TBL] [Abstract][Full Text] [Related]
20. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
Plenge P; Mellerup ET; Laursen H
Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
